Skip to main content
SpringerLink
Log in

Axitinib/sunitinib

Osteonecrosis of the jaw: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • van Cann T, et al. Incidence of medication-related osteonecrosis of the jaw in patients treated with both bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitors. Supportive Care in Cancer 26: 869-878, No. 3, Mar 2018. Available from: URL: http://doi.org/10.1007/s00520-017-3903-5 - Belgium

    Article  CAS  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Axitinib/sunitinib. Reactions Weekly 1689, 39 (2018). https://doi.org/10.1007/s40278-018-41908-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-41908-8

Search

Navigation